Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark CEO Mike Hsu told CNBC's Jim Cramer that his company's acquisition of Tylenol maker Kenvue will create value for shareholders, even as the pain reliever is scrutinized by the Trump ...

Irving-based Kimberly-Clark announced a deal today that will take it boldly into the pharmaceutical space as it acquires the under-fire maker of Tylenol. The consumer goods giant behind brands like ...

Read full article: Judge Lina Hidalgo announces separation from husband after 1 year of marriage 2 News' Amy Davis is showing you how you can score treats and meals for a fraction of what you'd ...